Bicyclic Peptide Technology Targets Extracellular Proteins for Degradation
Bicyclic cell-penetrating peptide chimeras (CPPTACs) selectively degrade extracellular and cell membrane proteins via endocytosis and lysosomal delivery.
Quick Facts
What This Study Found
Bicyclic CPPTACs selectively degrade extracellular and cell surface proteins through CPP-induced endocytosis and lysosomal delivery.
Key Numbers
How They Did This
Peptide chemistry: conjugation of bicyclic CPP (KRK motif) with target-binding elements; demonstration of endocytosis-mediated protein degradation.
Why This Research Matters
Targeted protein degradation is revolutionizing drug development, but most technologies only work on intracellular proteins. CPPTACs extend this approach to the much larger pool of extracellular targets.
The Bigger Picture
Expanding targeted protein degradation to extracellular targets could enable treatment of diseases driven by surface receptors, secreted growth factors, and circulating proteins.
What This Study Doesn't Tell Us
Early-stage proof-of-concept; in vivo stability, selectivity, and safety need extensive testing; manufacturing of bicyclic peptide conjugates may be complex.
Questions This Raises
- ?Which extracellular disease targets are most amenable to CPPTAC degradation?
- ?How does CPPTAC selectivity compare to antibody-based approaches?
Trust & Context
- Key Stat:
- Extracellular protein degradation CPPTACs extend targeted protein degradation beyond intracellular targets to cell surface and secreted proteins
- Evidence Grade:
- Proof-of-concept chemistry/biology study — demonstrates a novel technology platform but is very early stage.
- Study Age:
- Published 2026 in Bioorganic & Medicinal Chemistry Letters.
- Original Title:
- Bicyclic peptide-based CPPTACs for extracellular and cell membrane protein degradation.
- Published In:
- Bioorganic & medicinal chemistry letters, 132, 130496 (2026)
- Authors:
- Bai, Jinyu, Shi, Huaihuai, Chen, Jitun, Tian, Hui, Liang, Jiaxin, Chen, Bichun, Li, Jiazhong, Fang, Lijing
- Database ID:
- RPEP-14812
Evidence Hierarchy
Frequently Asked Questions
What is targeted protein degradation?
It's a therapeutic strategy that hijacks the cell's waste disposal system to destroy specific disease-causing proteins, rather than just blocking their function like traditional drugs.
Why is degrading extracellular proteins difficult?
Most protein degradation machinery is inside cells. Getting extracellular proteins inside cells and to the degradation machinery requires special delivery strategies like these bicyclic peptides.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14812APA
Bai, Jinyu; Shi, Huaihuai; Chen, Jitun; Tian, Hui; Liang, Jiaxin; Chen, Bichun; Li, Jiazhong; Fang, Lijing. (2026). Bicyclic peptide-based CPPTACs for extracellular and cell membrane protein degradation.. Bioorganic & medicinal chemistry letters, 132, 130496. https://doi.org/10.1016/j.bmcl.2025.130496
MLA
Bai, Jinyu, et al. "Bicyclic peptide-based CPPTACs for extracellular and cell membrane protein degradation.." Bioorganic & medicinal chemistry letters, 2026. https://doi.org/10.1016/j.bmcl.2025.130496
RethinkPeptides
RethinkPeptides Research Database. "Bicyclic peptide-based CPPTACs for extracellular and cell me..." RPEP-14812. Retrieved from https://rethinkpeptides.com/research/bai-2026-bicyclic-peptidebased-cpptacs-for
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.